CRISPR-Cas9 genome editing of a single regulatory element nearly abolishes target gene expression in mice--brief

Yu Han1, Orazio J Slivano1, Christine K Christie1

  • 1From the Aab Cardiovascular Research Institute, Department of Medicine, University of Rochester Medical Center, Rochester, NY (Y.H., O.J.S., C.K.C., J.M.M.); and Jackson Laboratories, Bar Harbor, ME (A.W.C.).

Abstract